Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2025-2031

March 2025 | 88 pages | ID: GAD4E0E6F89AEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Irritable Bowel Syndrome (IBS) market size is predicted to grow from US$ 6941 million in 2025 to US$ 16530 million in 2031; it is expected to grow at a CAGR of 15.6% from 2025 to 2031.

Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.

North America is the largest region of Irritable Bowel Syndrome (IBS), with a market share about 75%. Allergan, Valeant Pharmaceuticals, Takeda, Sucampo Pharmaceuticals and McNeil Consumer Healthcare are the top 5 manufacturers of industry, and they had about 80% combined market share.

LPI (LP Information)' newest research report, the “Irritable Bowel Syndrome (IBS) Industry Forecast” looks at past sales and reviews total world Irritable Bowel Syndrome (IBS) sales in 2024, providing a comprehensive analysis by region and market sector of projected Irritable Bowel Syndrome (IBS) sales for 2025 through 2031. With Irritable Bowel Syndrome (IBS) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Irritable Bowel Syndrome (IBS) industry.

This Insight Report provides a comprehensive analysis of the global Irritable Bowel Syndrome (IBS) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Irritable Bowel Syndrome (IBS) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Irritable Bowel Syndrome (IBS) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Irritable Bowel Syndrome (IBS) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Irritable Bowel Syndrome (IBS).

This report presents a comprehensive overview, market shares, and growth opportunities of Irritable Bowel Syndrome (IBS) market by product type, application, key players and key regions and countries.

Segmentation by Type:

• IBS-D Drug
• IBS-C Drug
• Others

Segmentation by Application:

• Women
• Men

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Bausch Health
• Allergan
• Takeda
• Sucampo Pharmaceuticals (Mallinckrodt)
• Sebela Pharmaceuticals Inc
• Astellas Pharmaceuticals

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Irritable Bowel Syndrome (IBS) Market Size (2020-2031)
  2.1.2 Irritable Bowel Syndrome (IBS) Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Irritable Bowel Syndrome (IBS) by Country/Region (2020, 2024 & 2031)
2.2 Irritable Bowel Syndrome (IBS) Segment by Type
  2.2.1 IBS-D Drug
  2.2.2 IBS-C Drug
  2.2.3 Others
2.3 Irritable Bowel Syndrome (IBS) Market Size by Type
  2.3.1 Irritable Bowel Syndrome (IBS) Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2020-2025)
2.4 Irritable Bowel Syndrome (IBS) Segment by Application
  2.4.1 Women
  2.4.2 Men
2.5 Irritable Bowel Syndrome (IBS) Market Size by Application
  2.5.1 Irritable Bowel Syndrome (IBS) Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2020-2025)

3 IRRITABLE BOWEL SYNDROME (IBS) MARKET SIZE BY PLAYER

3.1 Irritable Bowel Syndrome (IBS) Market Size Market Share by Player
  3.1.1 Global Irritable Bowel Syndrome (IBS) Revenue by Player (2020-2025)
  3.1.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Player (2020-2025)
3.2 Global Irritable Bowel Syndrome (IBS) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 IRRITABLE BOWEL SYNDROME (IBS) BY REGION

4.1 Irritable Bowel Syndrome (IBS) Market Size by Region (2020-2025)
4.2 Global Irritable Bowel Syndrome (IBS) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Irritable Bowel Syndrome (IBS) Market Size Growth (2020-2025)
4.4 APAC Irritable Bowel Syndrome (IBS) Market Size Growth (2020-2025)
4.5 Europe Irritable Bowel Syndrome (IBS) Market Size Growth (2020-2025)
4.6 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Irritable Bowel Syndrome (IBS) Market Size by Country (2020-2025)
5.2 Americas Irritable Bowel Syndrome (IBS) Market Size by Type (2020-2025)
5.3 Americas Irritable Bowel Syndrome (IBS) Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Irritable Bowel Syndrome (IBS) Market Size by Region (2020-2025)
6.2 APAC Irritable Bowel Syndrome (IBS) Market Size by Type (2020-2025)
6.3 APAC Irritable Bowel Syndrome (IBS) Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2020-2025)
7.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2020-2025)
7.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Irritable Bowel Syndrome (IBS) by Region (2020-2025)
8.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type (2020-2025)
8.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL IRRITABLE BOWEL SYNDROME (IBS) MARKET FORECAST

10.1 Global Irritable Bowel Syndrome (IBS) Forecast by Region (2026-2031)
  10.1.1 Global Irritable Bowel Syndrome (IBS) Forecast by Region (2026-2031)
  10.1.2 Americas Irritable Bowel Syndrome (IBS) Forecast
  10.1.3 APAC Irritable Bowel Syndrome (IBS) Forecast
  10.1.4 Europe Irritable Bowel Syndrome (IBS) Forecast
  10.1.5 Middle East & Africa Irritable Bowel Syndrome (IBS) Forecast
10.2 Americas Irritable Bowel Syndrome (IBS) Forecast by Country (2026-2031)
  10.2.1 United States Market Irritable Bowel Syndrome (IBS) Forecast
  10.2.2 Canada Market Irritable Bowel Syndrome (IBS) Forecast
  10.2.3 Mexico Market Irritable Bowel Syndrome (IBS) Forecast
  10.2.4 Brazil Market Irritable Bowel Syndrome (IBS) Forecast
10.3 APAC Irritable Bowel Syndrome (IBS) Forecast by Region (2026-2031)
  10.3.1 China Irritable Bowel Syndrome (IBS) Market Forecast
  10.3.2 Japan Market Irritable Bowel Syndrome (IBS) Forecast
  10.3.3 Korea Market Irritable Bowel Syndrome (IBS) Forecast
  10.3.4 Southeast Asia Market Irritable Bowel Syndrome (IBS) Forecast
  10.3.5 India Market Irritable Bowel Syndrome (IBS) Forecast
  10.3.6 Australia Market Irritable Bowel Syndrome (IBS) Forecast
10.4 Europe Irritable Bowel Syndrome (IBS) Forecast by Country (2026-2031)
  10.4.1 Germany Market Irritable Bowel Syndrome (IBS) Forecast
  10.4.2 France Market Irritable Bowel Syndrome (IBS) Forecast
  10.4.3 UK Market Irritable Bowel Syndrome (IBS) Forecast
  10.4.4 Italy Market Irritable Bowel Syndrome (IBS) Forecast
  10.4.5 Russia Market Irritable Bowel Syndrome (IBS) Forecast
10.5 Middle East & Africa Irritable Bowel Syndrome (IBS) Forecast by Region (2026-2031)
  10.5.1 Egypt Market Irritable Bowel Syndrome (IBS) Forecast
  10.5.2 South Africa Market Irritable Bowel Syndrome (IBS) Forecast
  10.5.3 Israel Market Irritable Bowel Syndrome (IBS) Forecast
  10.5.4 Turkey Market Irritable Bowel Syndrome (IBS) Forecast
10.6 Global Irritable Bowel Syndrome (IBS) Forecast by Type (2026-2031)
10.7 Global Irritable Bowel Syndrome (IBS) Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Irritable Bowel Syndrome (IBS) Forecast

11 KEY PLAYERS ANALYSIS

11.1 Bausch Health
  11.1.1 Bausch Health Company Information
  11.1.2 Bausch Health Irritable Bowel Syndrome (IBS) Product Offered
  11.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Bausch Health Main Business Overview
  11.1.5 Bausch Health Latest Developments
11.2 Allergan
  11.2.1 Allergan Company Information
  11.2.2 Allergan Irritable Bowel Syndrome (IBS) Product Offered
  11.2.3 Allergan Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Allergan Main Business Overview
  11.2.5 Allergan Latest Developments
11.3 Takeda
  11.3.1 Takeda Company Information
  11.3.2 Takeda Irritable Bowel Syndrome (IBS) Product Offered
  11.3.3 Takeda Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Takeda Main Business Overview
  11.3.5 Takeda Latest Developments
11.4 Sucampo Pharmaceuticals (Mallinckrodt)
  11.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Company Information
  11.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product Offered
  11.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Main Business Overview
  11.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Latest Developments
11.5 Sebela Pharmaceuticals Inc
  11.5.1 Sebela Pharmaceuticals Inc Company Information
  11.5.2 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product Offered
  11.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Sebela Pharmaceuticals Inc Main Business Overview
  11.5.5 Sebela Pharmaceuticals Inc Latest Developments
11.6 Astellas Pharmaceuticals
  11.6.1 Astellas Pharmaceuticals Company Information
  11.6.2 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Offered
  11.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Astellas Pharmaceuticals Main Business Overview
  11.6.5 Astellas Pharmaceuticals Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Irritable Bowel Syndrome (IBS) Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Irritable Bowel Syndrome (IBS) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of IBS-D Drug
Table 4. Major Players of IBS-C Drug
Table 5. Major Players of Others
Table 6. Irritable Bowel Syndrome (IBS) Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Irritable Bowel Syndrome (IBS) Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2020-2025)
Table 9. Irritable Bowel Syndrome (IBS) Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Irritable Bowel Syndrome (IBS) Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2020-2025)
Table 12. Global Irritable Bowel Syndrome (IBS) Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Player (2020-2025)
Table 14. Irritable Bowel Syndrome (IBS) Key Players Head office and Products Offered
Table 15. Irritable Bowel Syndrome (IBS) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Irritable Bowel Syndrome (IBS) Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Region (2020-2025)
Table 20. Global Irritable Bowel Syndrome (IBS) Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Irritable Bowel Syndrome (IBS) Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Irritable Bowel Syndrome (IBS) Market Size Market Share by Country (2020-2025)
Table 24. Americas Irritable Bowel Syndrome (IBS) Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2020-2025)
Table 26. Americas Irritable Bowel Syndrome (IBS) Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2020-2025)
Table 28. APAC Irritable Bowel Syndrome (IBS) Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Irritable Bowel Syndrome (IBS) Market Size Market Share by Region (2020-2025)
Table 30. APAC Irritable Bowel Syndrome (IBS) Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Irritable Bowel Syndrome (IBS) Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Irritable Bowel Syndrome (IBS) Market Size Market Share by Country (2020-2025)
Table 34. Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Irritable Bowel Syndrome (IBS)
Table 40. Key Market Challenges & Risks of Irritable Bowel Syndrome (IBS)
Table 41. Key Industry Trends of Irritable Bowel Syndrome (IBS)
Table 42. Global Irritable Bowel Syndrome (IBS) Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Irritable Bowel Syndrome (IBS) Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Irritable Bowel Syndrome (IBS) Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Irritable Bowel Syndrome (IBS) Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Bausch Health Details, Company Type, Irritable Bowel Syndrome (IBS) Area Served and Its Competitors
Table 47. Bausch Health Irritable Bowel Syndrome (IBS) Product Offered
Table 48. Bausch Health Irritable Bowel Syndrome (IBS) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Bausch Health Main Business
Table 50. Bausch Health Latest Developments
Table 51. Allergan Details, Company Type, Irritable Bowel Syndrome (IBS) Area Served and Its Competitors
Table 52. Allergan Irritable Bowel Syndrome (IBS) Product Offered
Table 53. Allergan Irritable Bowel Syndrome (IBS) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Allergan Main Business
Table 55. Allergan Latest Developments
Table 56. Takeda Details, Company Type, Irritable Bowel Syndrome (IBS) Area Served and Its Competitors
Table 57. Takeda Irritable Bowel Syndrome (IBS) Product Offered
Table 58. Takeda Irritable Bowel Syndrome (IBS) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Takeda Main Business
Table 60. Takeda Latest Developments
Table 61. Sucampo Pharmaceuticals (Mallinckrodt) Details, Company Type, Irritable Bowel Syndrome (IBS) Area Served and Its Competitors
Table 62. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product Offered
Table 63. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Sucampo Pharmaceuticals (Mallinckrodt) Main Business
Table 65. Sucampo Pharmaceuticals (Mallinckrodt) Latest Developments
Table 66. Sebela Pharmaceuticals Inc Details, Company Type, Irritable Bowel Syndrome (IBS) Area Served and Its Competitors
Table 67. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product Offered
Table 68. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Sebela Pharmaceuticals Inc Main Business
Table 70. Sebela Pharmaceuticals Inc Latest Developments
Table 71. Astellas Pharmaceuticals Details, Company Type, Irritable Bowel Syndrome (IBS) Area Served and Its Competitors
Table 72. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Offered
Table 73. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Astellas Pharmaceuticals Main Business
Table 75. Astellas Pharmaceuticals Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Irritable Bowel Syndrome (IBS) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Irritable Bowel Syndrome (IBS) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Irritable Bowel Syndrome (IBS) Sales Market Share by Country/Region (2024)
Figure 8. Irritable Bowel Syndrome (IBS) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Type in 2024
Figure 10. Irritable Bowel Syndrome (IBS) in Women
Figure 11. Global Irritable Bowel Syndrome (IBS) Market: Women (2020-2025) & ($ millions)
Figure 12. Irritable Bowel Syndrome (IBS) in Men
Figure 13. Global Irritable Bowel Syndrome (IBS) Market: Men (2020-2025) & ($ millions)
Figure 14. Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Application in 2024
Figure 15. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Player in 2024
Figure 16. Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Region (2020-2025)
Figure 17. Americas Irritable Bowel Syndrome (IBS) Market Size 2020-2025 ($ millions)
Figure 18. APAC Irritable Bowel Syndrome (IBS) Market Size 2020-2025 ($ millions)
Figure 19. Europe Irritable Bowel Syndrome (IBS) Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size 2020-2025 ($ millions)
Figure 21. Americas Irritable Bowel Syndrome (IBS) Value Market Share by Country in 2024
Figure 22. United States Irritable Bowel Syndrome (IBS) Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Irritable Bowel Syndrome (IBS) Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Irritable Bowel Syndrome (IBS) Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Irritable Bowel Syndrome (IBS) Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Irritable Bowel Syndrome (IBS) Market Size Market Share by Region in 2024
Figure 27. APAC Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2020-2025)
Figure 28. APAC Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2020-2025)
Figure 29. China Irritable Bowel Syndrome (IBS) Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Irritable Bowel Syndrome (IBS) Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Irritable Bowel Syndrome (IBS) Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Irritable Bowel Syndrome (IBS) Market Size Growth 2020-2025 ($ millions)
Figure 33. India Irritable Bowel Syndrome (IBS) Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Irritable Bowel Syndrome (IBS) Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Irritable Bowel Syndrome (IBS) Market Size Market Share by Country in 2024
Figure 36. Europe Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2020-2025)
Figure 37. Europe Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2020-2025)
Figure 38. Germany Irritable Bowel Syndrome (IBS) Market Size Growth 2020-2025 ($ millions)
Figure 39. France Irritable Bowel Syndrome (IBS) Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Irritable Bowel Syndrome (IBS) Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Irritable Bowel Syndrome (IBS) Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Irritable Bowel Syndrome (IBS) Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Irritable Bowel Syndrome (IBS) Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Irritable Bowel Syndrome (IBS) Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Irritable Bowel Syndrome (IBS) Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Irritable Bowel Syndrome (IBS) Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Irritable Bowel Syndrome (IBS) Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Irritable Bowel Syndrome (IBS) Market Size 2026-2031 ($ millions)
Figure 52. APAC Irritable Bowel Syndrome (IBS) Market Size 2026-2031 ($ millions)
Figure 53. Europe Irritable Bowel Syndrome (IBS) Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size 2026-2031 ($ millions)
Figure 55. United States Irritable Bowel Syndrome (IBS) Market Size 2026-2031 ($ millions)
Figure 56. Canada Irritable Bowel Syndrome (IBS) Market Size 2026-2031 ($ millions)
Figure 57. Mexico Irritable Bowel Syndrome (IBS) Market Size 2026-2031 ($ millions)
Figure 58. Brazil Irritable Bowel Syndrome (IBS) Market Size 2026-2031 ($ millions)
Figure 59. China Irritable Bowel Syndrome (IBS) Market Size 2026-2031 ($ millions)
Figure 60. Japan Irritable Bowel Syndrome (IBS) Market Size 2026-2031 ($ millions)
Figure 61. Korea Irritable Bowel Syndrome (IBS) Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Irritable Bowel Syndrome (IBS) Market Size 2026-2031 ($ millions)
Figure 63. India Irritable Bowel Syndrome (IBS) Market Size 2026-2031 ($ millions)
Figure 64. Australia Irritable Bowel Syndrome (IBS) Market Size 2026-2031 ($ millions)
Figure 65. Germany Irritable Bowel Syndrome (IBS) Market Size 2026-2031 ($ millions)
Figure 66. France Irritable Bowel Syndrome (IBS) Market Size 2026-2031 ($ millions)
Figure 67. UK Irritable Bowel Syndrome (IBS) Market Size 2026-2031 ($ millions)
Figure 68. Italy Irritable Bowel Syndrome (IBS) Market Size 2026-2031 ($ millions)
Figure 69. Russia Irritable Bowel Syndrome (IBS) Market Size 2026-2031 ($ millions)
Figure 70. Egypt Irritable Bowel Syndrome (IBS) Market Size 2026-2031 ($ millions)
Figure 71. South Africa Irritable Bowel Syndrome (IBS) Market Size 2026-2031 ($ millions)
Figure 72. Israel Irritable Bowel Syndrome (IBS) Market Size 2026-2031 ($ millions)
Figure 73. Turkey Irritable Bowel Syndrome (IBS) Market Size 2026-2031 ($ millions)
Figure 74. Global Irritable Bowel Syndrome (IBS) Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Irritable Bowel Syndrome (IBS) Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Irritable Bowel Syndrome (IBS) Market Size 2026-2031 ($ millions)